Prescription drug · NDA
Zemplar (Paricalcitol) NDC 0074-1658
Paricalcitol 5 ug/mL · Injection, Solution · Intravenous · AbbVie Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0074-1658-01 | 00074165801 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0074-1658-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 17, 1998 | |
| 0074-1658-05 | 00074165805 | 25 VIAL, MULTI-DOSE in 1 TRAY (0074-1658-05) / 2 mL in 1 VIAL, MULTI-DOSEMarketed from Apr 17, 1998 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zemplar
- Generic name (nonproprietary)
- paricalcitol
- Active ingredients
- Paricalcitol — 5 ug/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- AbbVie Inc.NDC labeler code 0074
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020819
- Marketing start
- Listing expires
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 0074-1658_f4535810-3437-4f7d-bef6-dab6fc10973cSPL ID f4535810-3437-4f7d-bef6-dab6fc10973cSPL set ID 7259652f-81bc-4ad1-bba5-d01f9fac1b80RxCUI 200321, 213298, 352076, 1736919, 1736921, 1736931UNII 6702D36OG5
- Pharmacologic class
- Vitamin D Analog; Vitamin D2 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400074165801followed by a unit qualifier and the quantityPackage 00074-1658-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZEMPLAR is indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease (CKD) on dialysis. ZEMPLAR is a vitamin D analog indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease on dialysis ( 1 ).
Excerpt only. Read the full label for complete information.
About NDC 0074-1658
- What is NDC 0074-1658?
- 0074-1658 is the product NDC for Zemplar (paricalcitol), Paricalcitol 5 ug/mL injection, solution, listed with the FDA by AbbVie Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zemplar (Paricalcitol).
- What is the active ingredient?
- Paricalcitol.
- Who is the labeler?
- AbbVie Inc., NDC labeler code 0074. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zemplar?
- 3 other product NDCs are listed under this name. See all Zemplar NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zemplar products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zemplarparicalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | AbbVie Inc. | 0074-9036 | 00074-9036-30 |
| Zemplarparicalcitol | Paricalcitol 2 ug/1 | Capsule, Liquid filledOral | AbbVie Inc. | 0074-9037 | 00074-9037-30 |
| Zemplarparicalcitol | Paricalcitol 2 ug/mL | Injection, SolutionIntravenous | AbbVie Inc. | 0074-4637 | 00074-4637-01 |
Other NDCs under NDA 020819
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zemplarparicalcitol | Paricalcitol 2 ug/mL | Injection, SolutionIntravenous | AbbVie Inc. | 0074-4637 |